Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients

被引：0
|
作者：
Gomez-Ayerbe, C. [1 ,2 ]
Palacios, R. [1 ,2 ]
Perez, C. [1 ,2 ]
Tellez, F. [3 ]
Sayago, C. [4 ]
Rios, M. J. [5 ]
Martin-Aspas, A. [6 ]
Camacho, A. [7 ]
Munoz, L. [8 ]
Santos, J. [1 ,2 ]
机构：
[1] Hosp Univ Virgen Victoria, Malaga, Spain
[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[3] Hosp Univ Puerto Real, Puerto Real, Spain
[4] Hosp Univ Virgen Valme, Seville, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Hosp Univ Puerta Mar, Cadiz, Spain
[7] Hosp Univ Reina Sofia, Cordoba, Spain
[8] Hosp Univ San Cecilio, Granada, Spain
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE37/23
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [41] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
    Carrasco, Itziar
    Sainz, Talia
    Antoinette Frick, Marie
    Jimenez de Ory, Santiago
    Fortuny, Claudia
    Burgos, Joaquin
    Montero, Marta
    Gavilan, Cesar
    Dolores Falcon, Maria
    Antonio Couceiro, Jose
    Ignacio Bernardino, Jose
    Bisbal, Otilia
    Guerrero, Carmelo
    Teresa Aldamiz-Echevarria, Maria
    Berenguer, Juan
    Luisa Navarro, Maria
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
  • [42] Treatment of HCV Infection with Direct-acting Antiviral Agents in Patients with HIV/HCV Co-infection: A Systematic Review
    Alavian, Seyed Moayed
    Dolatimehr, Fardin
    Sharafi, Heidar
    Safi-Abadi, Mahdi
    Rezaee-Zavareh, Mohammad Saeid
    Bayatpour, Mohammad Ehsan
    Karimi-Sari, Hamidreza
    Mohazzab-Torabi, Saman
    HEPATITIS MONTHLY, 2018, 18 (12)
  • [43] Partial restoration of brain structural and connectivity changes after HCV cure with direct acting antivirals (DAA)
    Marino, Zoe
    Carlos Pariente, Jose
    Munoz-Moreno, Emma
    Bartres, Concepcio
    Nacar, Loreto
    Cavero, Myriam
    Lens, Sabela
    Rodriguez-Tajes, Sergio
    Navines, Ricard
    Canizares, Silvia
    Forns, Xavier
    Bargallo, Nuria
    Martin-Santos, Rocio
    JOURNAL OF HEPATOLOGY, 2020, 73 : S626 - S626
  • [44] The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals
    Chromy, David
    Bauer, David Jm
    Simbrunner, Benedikt
    Jachs, Mathias
    Hartl, Lukas
    Schwabl, Philipp
    Schwarz, Caroline
    Rieger, Armin
    Grabmeier-Pfistershammer, Katharina
    Mandorfer, Mattias
    Trauner, Michael
    Ferenci, Peter
    Gschwantler, Michael
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2022, 77 : S555 - S555
  • [45] The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals
    Chromy, David
    Bauer, David J. M.
    Simbrunner, Benedikt
    Jachs, Matthias
    Hartl, Lukas
    Schwabl, Philipp
    Schwarz, Caroline
    Rieger, Armin
    Grabmeier-Pfistershammer, Katharina
    Trauner, Michael
    Ferenci, Peter
    Mandorfer, Mattias
    Gschwantler, Michael
    Reiberger, Thomas
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (05) : 385 - 394
  • [46] IMPACT OF HEPATITIS C VIRUS (HCV) ERADICATION FOLLOWING DIRECT ACTING ANTIVIRALS TREATMENT (DAA) ON LIVER STIFFNESS MEASUREMENT (LSM)
    Khalil, Mohammed Tag-Adeen S.
    Sapra, Ahlam M.
    Akazawa, Yuko
    Ohnita, Ken
    Nakao, Kazuhiko
    GASTROENTEROLOGY, 2017, 152 (05) : S1105 - S1106
  • [47] Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
    Dietz, Julia
    Susser, Simone
    Vermehren, Johannes
    Peiffer, Kai-Henrik
    Grammatikos, Georgios
    Berger, Annemarie
    Ferenci, Peter
    Buti, Maria
    Mullhaupt, Beat
    Hunyady, Bela
    Hinrichsen, Holger
    Mauss, Stefan
    Petersen, Joerg
    Buggisch, Peter
    Felten, Gisela
    Hueppe, Dietrich
    Knecht, Gaby
    Lutz, Thomas
    Schott, Eckart
    Berg, Christoph
    Spengler, Ulrich
    von Hahn, Thomas
    Berg, Thomas
    Zeuzem, Stefan
    Sarrazin, Christoph
    GASTROENTEROLOGY, 2018, 154 (04) : 976 - +
  • [48] HCV treatment with direct-acting antivirals (DAAs) in HIV/HCV coinfected subjects affects the dynamics of the HIV-1 reservoir
    Ghiglione, Y.
    Polo, M. L.
    Solomon, A.
    Poblete, G.
    Rolon, M. J.
    Patterson, P.
    Perez, H.
    Salomon, H.
    Quiroga, F.
    Turk, G.
    Lewin, S. R.
    Laufer, N.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 95 - 95
  • [49] GLOMERULAR FILTRATION RATES AND NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN DURING TREATMENT WITH DIRECT ACTING ANTIVIRALS (DAA) FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
    Coppolino, Giuseppe
    Strazzulla, Alessio
    Barreca, Giorgio
    Gentile, Innocenza
    Rivoli, Laura
    Postorino, Maria Concetta
    Mazzitelli, Maria
    Greco, Giuseppe
    Costa, Chiara
    Pisani, Vincenzo
    Marascio, Nadia
    Simeoni, Maria Adelina
    Foca, Alfredo
    Foti, Daniela
    Gulletta, Elio
    Fuiano, Giorgio
    Torti, Carlo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [50] First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever Reply
    Shafran, Stephen D.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (07) : 949 - +
12345